- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/26 - Radicals substituted by sulfur atoms
Patent holdings for IPC class C07D 277/26
Total number of patents in this class: 95
10-year publication summary
|
5
|
9
|
4
|
11
|
5
|
9
|
9
|
3
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Red Bull GmbH | 881 |
8 |
| Bayer Pharma AG | 1086 |
4 |
| Dow AgroSciences LLC | 1238 |
4 |
| Enanta Pharmaceuticals, Inc. | 424 |
4 |
| Sanford Burnham Prebys Medical Discovery Institute | 280 |
4 |
| Merck Sharp & Dohme LLC | 3752 |
4 |
| Avexxin AS | 49 |
3 |
| The Institute of Cancer Research: Royal Cancer Hospital | 184 |
3 |
| Kumiai Chemical Industry Co., Ltd. | 317 |
3 |
| BASF SE | 20421 |
2 |
| GlycoFi, Inc. | 24 |
2 |
| Kancera AB | 29 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 577 |
2 |
| Oregon Health & Science University | 758 |
2 |
| Seoul National University Industry Foundation | 363 |
2 |
| Shin Nippon Biomedical Laboratories, Ltd. | 82 |
2 |
| Universite de droit et de La Sante de Lille 2 | 39 |
2 |
| Paris Sciences et Lettres - Quartier Latin | 200 |
2 |
| Migal Galilee Research Institute Ltd. | 54 |
2 |
| Corteva Agriscience LLC | 2682 |
2 |
| Other owners | 36 |